Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Downloads

Investor Inquiries

Press Releases

Press Releases

  • Nov 08, 2021
    Wave Life Sciences to Present at the Stifel 2021 Virtual Healthcare Conference
    CAMBRIDGE, Mass. , Nov. 08, 2021 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd.  (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive
  • Oct 18, 2021
    Wave Life Sciences and Takeda Amend CNS Collaboration
    Amendment to ongoing collaboration allows Wave to advance or partner CNS programs, including those using ADAR editing Takeda option to co-develop and co-commercialize late-stage CNS programs, including clinical programs WVE-004 and WVE-003, remains unchanged CAMBRIDGE, Mass. , Oct.